GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Additional Paid-In Capital

Achiko AG (Achiko AG) Additional Paid-In Capital : $19.99 Mil(As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Additional Paid-In Capital?


Achiko AG's quarterly additional paid-in capital increased from Jun. 2021 ($16.56 Mil) to Dec. 2021 ($19.99 Mil) but then stayed the same from Dec. 2021 ($19.99 Mil) to Jun. 2022 ($19.99 Mil).

Achiko AG's annual additional paid-in capital increased from Dec. 2019 ($11.65 Mil) to Dec. 2020 ($14.23 Mil) and increased from Dec. 2020 ($14.23 Mil) to Dec. 2021 ($19.99 Mil).


Achiko AG Additional Paid-In Capital Historical Data

The historical data trend for Achiko AG's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Additional Paid-In Capital Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
Additional Paid-In Capital
3.15 11.65 14.23 19.99

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Additional Paid-In Capital Get a 7-Day Free Trial 9.15 14.23 16.56 19.99 19.99

Achiko AG Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Achiko AG Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Achiko AG's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Achiko AG (Achiko AG) Business Description

Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.